Surgical pulmonary valve replacement at a tertiary adult congenital heart centre in the current era.

ABSTRACT:

Background

Surgical pulmonary valve replacement (PVR) is the standard cardiac operation in adult patients with congenital heart disease (ACHD). We report recent experience at a large tertiary centre and examine the impact of prosthesis type on outcomes.

Methods

All surgical PVRs performed at our tertiary centre between January 2003 and December 2018 were included.

Results

The study population included 490 patients (197 women; mean age 29.9 ± 13 years). The types of valves used were Homograft 179 (37%), Perimount 152 (31%), Mosaic 120 (24%), Hancock 31 (6%), and others 5 (1%). Seven (1.4%) early deaths occurred within 30 days after surgery. The survival rates at 1, 5, 10, and 15 years of follow-up were 98.3%, 97.7%, 96.8%, and 95.4%, respectively, whereas freedom from

SUBMITTER: Kubota K 

PROVIDER: S-EPMC11657547 | biostudies-literature | 2022 Sep

REPOSITORIES: biostudies-literature